mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
0.25 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.1 |